Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Indian Vaccine Market Report by Monovalent and Combined Vaccines (BCG, HIB, Influenza, Varicella, Typhoid, Japanese Encephalitis, Measles, Tetanus Toxoid, Hepatitis A, Rubella, Diphtheria, Tetanus, and Pertussis (DPT), Oral Polio Vaccine (OPV), MMR, Rotavirus, Hepatitis B, Pneumococcal, Meningococcal, Rabies, HPV, Hexavalent, Dengue Vaccines) 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A554
Buy Now
Market Overview:
The Indian vaccine market size is expected to exhibit a growth rate (CAGR) of 12.3% during 2024-2032.
|
Report Attribute
|
Key Statistics
|
|---|---|
| Base Year | 2023 |
| Forecast Years | 2024-2032 |
| Historical Years |
2018-2023
|
|
Market Growth Rate 2024-2032
|
12.3% |
A vaccine is a biological substance that is developed to boost the immune system while protecting against bacterial and viral diseases. It comprises live attenuated, inactivated, toxoid, mRNA, viral vector, and subunit, recombinant, polysaccharide, and conjugate vaccines. It is consumed orally, by aerosol, or through injections to prevent several diseases, such as measles, polio, tetanus, influenza, rabies, and whooping cough. In addition, it stimulates the body to make antibodies against antigens or pathogens. At present, there is a rise in the production of vaccines in India due to technological advancements and the increasing number of cold chain storage facilities.
Indian Vaccine Market Trends:
The Government of India (GOI) is currently launching various campaigns, such as the Universal Immunization Program (UIP), to increase immunization coverage against vaccine-preventable diseases in the country. This, along with the growing health awareness among the masses, represents one of the key factors driving the market in India. Moreover, the rising export of generic medicines in India that imitates brand-name drugs in effect, strength, doses, qualities, forms, administration, and safety is contributing to the growth of the market. In addition, there is an increase in the number of private companies that are producing cost-effective vaccines and investing in their distribution throughout India. This, coupled with the burgeoning healthcare industry, is strengthening the growth of the market in the country. Besides this, key market players are extensively investing in research and development (R&D) activities to introduce new and enhanced vaccines. They are also focusing on developing innovative ways to distribute vaccines effectively within the country and international markets, which is catalyzing the demand for Indian vaccines. Other factors propelling the market growth are the increasing population, inflating income levels of individuals, improving existing vaccine infrastructure, the expanding logistics industry, and the growing participation of non-governmental organizations (NGOs).
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the Indian vaccine market report, along with forecasts for the period 2024-2032. Our report has categorized the market based on monovalent and combined vaccines.
Breakup by Monovalent and Combined Vaccines:
- BCG
- HIB
- Influenza
- Varicella
- Typhoid
- Japanese Encephalitis
- Measles
- Tetanus Toxoid
- Hepatitis A
- Rubella
- Diphtheria
- Tetanus, and Pertussis (DPT)
- Oral Polio Vaccine (OPV)
- MMR
- Rotavirus
- Hepatitis B
- Pneumococcal
- Meningococcal
- Rabies
- HPV
- Hexavalent
- Dengue vaccines
The Focus of the Analysis for Each Vaccine
- Vaccine Overview
- Historical and Current Market Trends
- Market Breakup by Prescriber
- Market Breakup by Public and Private Sector
- Market Outlook
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being GlaxoSmithKline, Sanofi Aventis, Serum Institute of India, Panacea Biotec, Pfizer, Novartis, VHB Lifesciences, Zydus Cadila and MSD.
Report Coverage:
| Report Features | Details |
|---|---|
| Base Year of the Analysis | 2023 |
| Historical Period | 2018-2023 |
| Forecast Period | 2024-2032 |
| Units | Million, INR Million |
|
Scope of the Report
|
Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
|
| Monovalent and Combined Vaccines Covered | BCG, HIB, Influenza, Varicella, Typhoid, Japanese Encephalitis, Measles, Tetanus Toxoid, Hepatitis A, Rubella, Diphtheria, Tetanus, and Pertussis (DPT), Oral Polio Vaccine (OPV), MMR, Rotavirus, Hepatitis B, Pneumococcal, Meningococcal, Rabies, HPV, Hexavalent, Dengue vaccines |
| Companies Covered | GlaxoSmithKline, Sanofi Aventis, Serum Institute of India, Panacea Biotec, Pfizer, Novartis, VHB Lifesciences, Zydus Cadila and MSD. |
| Customization Scope | 10% Free Customization |
| Report Price and Purchase Option | Single User License: US$ 2699 Five User License: US$ 3699 Corporate License: US$ 4699 |
| Post-Sale Analyst Support | 10-12 Weeks |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
We expect the Indian vaccine market to exhibit a CAGR of 12.3% during 2024-2032.
The rising prevalence of various infectious diseases, such as polio, measles, influenza, etc., along with the introduction of improved vaccines by pharmaceutical companies for fatal medical ailments, is primarily driving the Indian vaccine market.
The sudden outbreak of the COVID-19 pandemic has led to the growing utilization of novel vaccines across clinics, hospitals, and vaccination centers for immunization procedures to combat the spread of the coronavirus infection across the nation.
Based on the monovalent and combined vaccines, the Indian vaccine market can be bifurcated into BCG, HIB, influenza, varicella, typhoid, Japanese encephalitis, measles, tetanus toxoid, hepatitis A, rubella, Diphtheria, Tetanus, and Pertussis (DPT), Oral Polio Vaccine (OPV), MMR, rotavirus, hepatitis B, pneumococcal, meningococcal, rabies, HPV, hexavalent, and dengue vaccines. Currently, pneumococcal holds the majority of the total market share.
Some of the major players in the Indian vaccine market include GlaxoSmithKline, Sanofi Aventis, Serum Institute of India, Panacea Biotec, Pfizer, Novartis, VHB Lifesciences, Zydus Cadila, and MSD.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Purchase options
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More